Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens

Food and Chemical Toxicology

Volumn 47, Issue 4, 2009, Pages 787-795

  Dip, Ramiro ^a   Lenz, Sarah ^a   Gmuender, Hans ^b   Naegeli, Hanspeter ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b GENEDATA AG   (Switzerland)

Author keywords

Breast cancer; Estrogen receptor; Phytochemicals; Phytotoxins

Indexed keywords

COUMESTROL; DNA; ESTROGEN RECEPTOR; PHYTOESTROGEN; RESVERATROL; TRANSCRIPTOME;

ARTICLE; BREAST CANCER; CANCER CELL; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; ESTROGEN ACTIVITY; EXPOSURE; GENE; GENE CONTROL; GENE INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROARRAY ANALYSIS; PLEIOTROPY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; CELL SURVIVAL; DIET; FEMALE; GENE EXPRESSION PROFILING; HUMANS; PHYTOESTROGENS; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED;

EID: 60849121061     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.01.008     Document Type: Article

References (49)

1. Adami H.O., Signorello L.B., and Trichopoulos D. Towards an understanding of breast cancer etiology. Semin. Cancer Biol. 8 (1998) 255-262
2. Adlercreutz H., Fotsis T., Heikkinen R., Dwyer J.T., Woods M., Goldin B.R., and Gorbach S.L. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegeterian postmenopausal women and in women with breast cancer. Lancet 2 (1982) 1294-1295
3. Afshari C.A., Nuwaysir E.F., and Barrett J.C. Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. Cancer Res. 59 (1999) 4759-4760
4. Allred C.D., Allred K.F., Ju Y.H., Virant S.M., and Helferich W.G. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) cells in a dose-dependent manner. Cancer Res. 61 (2001) 5045-5050
5. Branca F., and Lorenzetti S. Health effects of phytoestrogens. Forum Nutr. 57 (2005) 100-111
6. Brian J.V., Harris C.A., Scholze M., Kortenkamp A., Booy P., Lamoree M., Pojana G., Jonkers N., Marcomini A., and Sumpter J.P. Evidence of estrogenic mixture effects on the reproductive performance of fish. Environ. Sci. Technol. 41 (2007) 337-344
7. Burczynski M.E., McMillian M., Ciervo J., Li L., Parker J.B., Dunn II R.T., Hicken S., Farr S., and Johnson M.D. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol. Sci. 58 (2000) 399-415
8. Buterin T., Koch C., and Naegeli H. Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. Carcinogenesis 27 (2006) 1567-1578
9. Charles G.D., Gennings C., Zacharewski T.R., Gollapudi B.B., and Carney E.W. An approach for assessing estrogen receptor-mediated interactions in mixtures of three chemicals: a pilot study. Toxicol. Sci. 68 (2002) 349-360
10. Clemons M., and Gross P. Estrogen and the risk of breast cancer. New Engl. J. Med. 344 (2001) 276-285
11. Colditz G.A., and Frazier A.L. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol. Biomarkers Prev. 4 (1995) 567-571
12. Frasor J., Danes J.M., Komm B., Chang K.C., Lyttle R., and Katzenellenbogen B.S. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144 (2003) 4562-4574
13. Hall J.M., Couse J.F., and Korach K.S. The multifaceted mechanism of estradiol and estrogen receptor signalling. J. Biol. Chem. 276 (2001) 36869-36872
14. Hargreaves D.F., Potten C.S., Harding C., Shaw L.E., Morton M.S., Roberts S.A., Howell A., and Bundred N.J. Two-week dietary supplementation has an estrogenic effect on normal premenopausal breast. J. Clin. Endocrinol. Metab. 84 (1999) 4017-4024
15. Heneweer M., Muusse M., van den Berg M., and Sanderson J.T. Additive estrogenic effects of mixtures of frequently used UV filters on pS2-gene transcription in MCF-7 cells. Toxicol. Appl. Pharmacol. 208 (2005) 170-177
16. Hsieh C.Y., Santell R.C., Haslam S.Z., and Helferich W.G. Estrogenic effects of genistein on the growth of extrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 58 (1998) 3833-3838
17. Ingram D., Sanders K., Kolybaba M., and Lopez D. Case-control study of phytoestrogens and breast cancer. Lancet 350 (1997) 990-994
18. Katzenellenbogen B.S., and Katzenellenbogen J.A. Estrogen receptor transcription and transactivation: estrogen receptor α and estrogen receptor β: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res. 2 (2000) 335-344
19. Kaufman R.H., and Adam E. Findings in female offspring of women exposed in utero to diethylstilbestrol. Obstet. Gynecol. 99 (2002) 197-200
20. Kortenkamp A. Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environ. Health Perspect. 115 Suppl. 1 (2007) 98-105
21. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Häggblad J., Nilsson S., and Gustafsson J.-A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138 (1997) 863-870
22. Lavigne J.A., Takahashi Y., Chandramouli G.V., Liu H., Perkins S.N., Hursting D., and Wang T.T. Concentration-dependent effects of genistein on global expression in MCF-7 breast cancer cells: an oligo microarray study. Breast Cancer Res. Treat. 110 (2007) 85-98
23. Legler J., van den Brink C.E., Brower A., Murk A.J., van der Saag P.T., Vethaak A.D., and van der Burg B. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol. Sci. 48 (1999) 55-66
24. Lobenhofer E.K., Bennett L., Cable P.L., Li L., Bushel P.R., and Afshari C.A. Regulation of DNA replication fork genes by 17β-estradiol. Mol. Endocrinol. 16 (2002) 1215-1229
25. Loewe S., and Muischnek H. Über Kombinationswirkungen. 1. Mitteilung: Hilfsmittel der Fragestellung. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol. 114 (1926) 313-326
26. Maffini M.V., Rubin B.S., Sonnenschein C., and Soto A.M. Endocrine disruptors and reproductive health: the case of bisphenol-A. Mol. Cell. Endocrinol. (2006) 179-186
27. Markey C.M., Rubin B.S., Soto A.M., and Sonnenschein C. Endocrine disruptors: from Wingspread to environmental developmental biology. J. Steroid. Biochem. Mol. Biol. 83 (2002) 235-244
28. Martinez M.E., Thomson C.A., and Smith-Warner S.A. Soy and breast cancer: the controversy continues. J. Natl. Cancer Inst. 98 (2006) 430-431
29. McCarty M.F. Isoflavones made simple-Genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. Med. Hypotheses 66 (2006) 1093-1114
30. McDonnell D.P., and Norris J.D. Connections and regulation of the human estrogen receptor. Science 296 (2002) 1642-1644
31. McMichael-Phillips D.F., Harding C., Morton M., Roberts S.A., Howell A., Potten C.S., and Bundred N.J. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am. J. Clin. Nutr. 62 (1998) 1431S-1436S
32. McPherson K., Steel C.M., and Dixon J.M. ABC of breast disease. Breast cancer-epidemiology, risk factors, and genetics. BMJ 321 (2000) 624-628
33. Messina M., McCaskill-Stevens W., and Lampe J.W. Addressing the soy and breast cancer relationship: review, commentary and workshop proceedings. J. Natl. Cancer Inst. 98 (2006) 1275-1284
34. Moggs J.G., and Orphanides G. Estrogen receptors: orchestrators of pleiotropic cellular responses. EMBO Rep. 9 (2001) 775-781
35. Naciff J.M., Jump M.L., Torontali S.M., Carr G.J., Tiesman J.P., Overmann G.J., and Daston G.P. Gene expression profile induced by 17β-ethynyl estradiol, bisphenol A, and genistein in the developing female reproductive system of the rat. Toxicol. Sci. 68 (2002) 184-199
36. Nelson H.D., Humphrey L.L., Nygren P., Teutsch S.M., and Allan J.D. Postmenopausal hormone replacement therapy: scientific review. JAMA 288 (2002) 872-881
37. Payne J., Scholze M., and Kortenkamp A. Mixtures of four organochlorines enhance human breast cancer cell proliferation. Environ. Health Perspect. 109 (2001) 391-397
38. Pennie W.D., Tugwood J.D., Oliver G.J., and Kimber I. The principles and practice of toxigenomics: applications and opportunities. Toxicol. Sci. 54 (2000) 277-283
39. Petrakis N.L., Barnes S., King E.B., Lowenstein J., Wiencke J., Lee M.M., Miike R., Kirk M., and Coward L. Stimulatory influence of soy protein isolate on breast secretion in pre and postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 5 (1996) 785-794
40. Rajapakse N., Silva E., Scholze M., and Kortenkamp A. Deviation from additivity with estrogenic mixtures containing 4-nonylphenol and 4-tert-octylphenol detected in the E-SCREEN assay. Environ. Sci. Technol. 38 (2004) 6343-6352
41. Rice S., and Whitehead S.A. Phytoestrogens and breast cancer-promoters or protectors?. Endocr. Relat. Cancer 13 (2006) 995-1015
42. Safe S.H. Transcriptional activation of genes by 17β-estradiol through estrogen-receptor-Sp1 interactions. Vitam. Horm. 62 (2001) 231-252
43. Shioda T., Chesnes J., Coser K.R., Zou L., Hur J., Dean K.L., Sonnenschein C., Soto A.M., and Isselbacher K.J. Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of xenoestrogens. Proc. Natl. Acad. Sci. USA 103 (2006) 12033-12038
44. Silva E., Rajapakse N., and Kortenkamp A. Something from "nothing"-eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ. Sci. Technol. 36 (2002) 1751-1756
45. Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olea N., and Serrano F.O. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ. Health Perspect. 103 Suppl. 7 (1995) 113-122
46. Swan S.H. Intrauterine exposure to diethylstilbestrol: long-term effects in humans. APMIS 108 (2000) 793-804
47. Tsubura A., Uehara N., Kiyozuka Y., and Shikata N. Dietary factors modifying breast cancer risk and relation to time of intake. J. Mammary Gland Biol. Neoplasia 10 (2005) 87-100
48. van Meeuwen J.A., ter Burg W., Piersma A.H., van den Berg M., and Sanderson J.T. Mixture effects of estrogenic compounds on proliferation and pS2 expression of MCF-7 human breast cancer cells. Food Chem. Toxicol. 45 (2007) 2319-2330
49. Vendrell J.A., Magnino F., Danis E., Duchesne M.J., Pinloche S., Pons M., Birnbaum D., Nguyen C., Theillet C., and Cohen P.A. Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J. Mol. Endocrinol. 32 (2004) 397-414